Investment firm Giverny Capital outlines its rationale for adding Watsco to its portfolio, highlighting a value-oriented strategy as markets remain dominated by AI euphoria. The firm's latest investor letter reveals a challenging quarter of narrow returns.
Investment firm Giverny Capital highlights insurance distributor TWFG as a key holding in its latest letter, revealing a challenging year where its value-focused strategy lagged the AI-fueled market rally.
Investors in lighting specialist FW Thorpe have seen a negative total shareholder return of 25% since 2021, starkly underperforming the broader market's gains. Despite steady revenue growth, the share price decline highlights a disconnect with company fundamentals.
The derivatives exchange is in early talks to reintroduce binary options for individual investors, aiming to capture the growing appetite for event-based wagering while staying within regulated financial markets.
U.S. stock futures tumbled Sunday night, extending a volatile start to 2026 as a historic collapse in gold and silver prices and a sharp downturn in Bitcoin sparked fears of a broader market deleveraging.
In a significant policy pivot, new CFTC Chairman Michael Selig is moving to establish clearer federal oversight for crypto-linked prediction markets, withdrawing restrictive proposals and signaling closer collaboration with the SEC. Analysts see this as a potential 'greenfield' opportunity for major platforms.
A new breed of online platforms is enabling speculation on housing market trends without the need to buy property, drawing both intrigued investors and sharp regulatory criticism.
While the German market gained a modest 7.7%, steel dust recycling leader Befesa (ETR:BFSA) delivered a total shareholder return of 54% over the past twelve months. This impressive rebound follows a challenging three-year period, sparking investor debate on whether it signals a sustained recovery or a temporary rally.
While AI continues to fuel a historic market rally, a closer look reveals troubling signs of overheating, from staggering capital expenditures to questionable monetization and complex financial engineering.
Cryptocurrency-linked equities faced renewed selling pressure ahead of Monday's market open, even as Bitcoin itself showed signs of stabilization following a volatile weekend.
Amid a sluggish housing sector, Installed Building Products (IBP) has demonstrated remarkable resilience, becoming a standout performer in Giverny Capital's portfolio. The insulation specialist's shares have surged over 50% in the past year, bucking broader market trends.
The Trump family-affiliated stablecoin USD1 has rapidly ascended to become a top-five stablecoin by market capitalization, reaching $5 billion, even as speculative meme tokens falter. Its growth is shadowed by a previously unreported deal with a UAE-backed entity and mounting regulatory scrutiny in Washington.
Tron founder Justin Sun reveals plans to acquire up to $100 million in Bitcoin amid a significant market downturn, positioning the move as a strategic accumulation opportunity.
U.S. stock futures pointed to a lower open Monday as investors braced for a flood of corporate earnings and crucial labor market reports that could sway Federal Reserve policy expectations.
A stark consensus is emerging among prediction market traders and analysts, with a 71% probability now priced in for Bitcoin to fall below $65,000 within two years. This bearish outlook follows a weekend sell-off to nine-month lows and is supported by underwater ETF positions, technical warnings, and concerns over a sustained market downturn rather than a temporary correction.
Cleveland-based KeyCorp (KEY) is riding a wave of positive analyst sentiment following a strong earnings beat, with its stock performance significantly outpacing broader market indices. The bank's diversified model and robust capital returns are fueling optimism for sustained growth.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
Amid a choppy market landscape in early 2026, value investors are scanning for opportunities. We analyze three companies—Viavi Solutions, Kontoor Brands, and Robert Half—whose current share prices appear significantly disconnected from their estimated intrinsic worth based on cash flow projections.
As markets navigate a volatile start to 2026, income-focused investors are turning to dividend payers for resilience. We analyze three companies with strong cash flows and shareholder return commitments.
